Ninth Circuit Revisits Merck Rules on Securities Fraud Limitations Period


The U.S. Court of Appeals for the Ninth Circuit overturned a district court’s holding that a securities fraud claim was time-barred, noting that the 2010 Supreme Court case Merck & Co. v. Reynolds had rejected “inquiry notice” as the bright-line test for the limitations period. The plaintiff alleged that he had sold his interest in Alchemix Corporation based on misrepresentations as to ongoing negotiations between Alchemix, AFG investment group, and Western Oil Sands. Alchemix countered that, in 2002, it sent the plaintiff a letter noting that negotiations with AFG had terminated, putting the plaintiff on inquiry notice to further investigate the circumstances surrounding the negotiations. Because the limitations period is the earliest of five years or two years after the discovery of facts constituting the violation, the district court held that receipt of the letter more than two years before the suit was filed barred litigation.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Katten Muchin Rosenman LLP | Attorney Advertising

Written by:


Katten Muchin Rosenman LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.